Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/74562
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amro M. Soliman | en_US |
dc.contributor.author | Ru Hui Sim | en_US |
dc.contributor.author | Srijit Das | en_US |
dc.contributor.author | Pasuk Mahakkanukrauh | en_US |
dc.date.accessioned | 2022-10-16T06:43:57Z | - |
dc.date.available | 2022-10-16T06:43:57Z | - |
dc.date.issued | 2022-05-01 | en_US |
dc.identifier.issn | 1875533X | en_US |
dc.identifier.issn | 09298673 | en_US |
dc.identifier.other | 2-s2.0-85130285474 | en_US |
dc.identifier.other | 10.2174/0929867328666210910154330 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85130285474&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/74562 | - |
dc.description.abstract | There is an increase in the incidence of inflammatory eye diseases worldwide. Several dysregulated inflammatory pathways, including the NOD-like receptor protein 3 (NLRP3) inflammasome, have been reported to contribute significantly to the pathogenesis and progression of ophthalmic diseases. Although the available allopathic/ conventional medicine has demonstrated effectiveness in managing eye diseases, there is an ongoing global demand for alternative therapeutics with minimal adverse drug reactions, easy availability, increase in patient compliance, and better disease outcomes. Therefore, several studies are investigating the utilization of natural products and herbal formulations in impeding inflammatory pathways, including the NLRP3 inflammasome, in order to prevent or manage eye diseases. In the present review, we highlight the recently reported inflammatory pathways with special emphasis on NLRP3 Inflammasomes involved in the development of eye diseases. Furthermore, we present a variety of natural products and phytochemicals that were reported to interfere with these pathways and their underlying mechanisms of action. These natural products represent potential therapeutic applications for the treatment of several inflammatory eye diseases. | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Chemistry | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Therapeutic Targeting of Inflammatory Pathways with Emphasis on NLRP3 Inflammasomes by Natural Products: A Novel Approach for the Treatment of Inflammatory Eye Diseases | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Current Medicinal Chemistry | en_US |
article.volume | 29 | en_US |
article.stream.affiliations | Sultan Qaboos University | en_US |
article.stream.affiliations | University of Alberta | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
article.stream.affiliations | Tanglin Health Clinic | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.